Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs

被引:9
作者
Ferraro, L
Tanganelli, S
Fuxe, K
Bebe, BW
Tomasini, MC
Rambert, FA
Antonelli, T
机构
[1] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy
[2] Karolinska Inst, Dept Neurosci, Stockholm, Sweden
[3] Lab L Lafon, Maisons Alfort, France
关键词
modafinil; fluoxetine; DL-Fenfluramine; paroxetine; serotonin transmission; sleep;
D O I
10.1016/S0006-8993(01)02000-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Modafinil did not affect spontaneous and K+-evoked [H-3]5-HT efflux from cortical synaptosomes while it increased K+-evoked tritium efflux from cortical slices, an action that became stronger in the presence of paroxetine. In contrast, DL-fenfluramine and fluoxetine were able to enhance spontaneous and/or K+-evoked tritium efflux from synaptosomes and slices. These results suggest that modafinil does not affect 5-HT transmission from cortical synaptosomes and that its 5-HT releasing action is different from that of DL-fenfluramine and fluoxetine. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 15 条
[1]   SUCCESSFUL TREATMENT OF IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY WITH MODAFINIL [J].
BASTUJI, H ;
JOUVET, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) :695-700
[2]   THE SUBSTITUTED AMPHETAMINES 3,4-METHYLENEDIOXYMETHAMPHETAMINE, METHAMPHETAMINE, PARA-CHLOROAMPHETAMINE AND FENFLURAMINE INDUCE 5-HYDROXYTRYPTAMINE RELEASE VIA A COMMON MECHANISM BLOCKED BY FLUOXETINE AND COCAINE [J].
BERGER, UV ;
GU, XF ;
AZMITIA, EC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :153-160
[3]   Health-related quality of life effects of modafinil for treatment of narcolepsy [J].
Beusterien, KM ;
Rogers, AE ;
Walsleben, JA ;
Emsellem, HA ;
Reblando, JA ;
Wang, LX ;
Goswami, M ;
Steinwald, B .
SLEEP, 1999, 22 (06) :757-765
[4]   Carrier-dependent and Ca2+-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and(+)-fenfluramine [J].
Crespi, D ;
Mennini, T ;
Gobbi, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1735-1743
[5]   CENTRAL ALPHA-1-ADRENERGIC STIMULATION IN RELATION TO THE BEHAVIOR STIMULATING EFFECT OF MODAFINIL - STUDIES WITH EXPERIMENTAL-ANIMALS [J].
DUTEIL, J ;
RAMBERT, FA ;
PESSONNIER, J ;
HERMANT, JF ;
GOMBERT, R ;
ASSOUS, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (01) :49-58
[6]   The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor [J].
Ferraro, L ;
Tanganelli, S ;
OConnor, WT ;
Antonelli, T ;
Rambert, F ;
Fuxe, K .
NEUROSCIENCE LETTERS, 1996, 220 (01) :5-8
[7]   Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil [J].
Ferraro, L ;
Fuxe, K ;
Tanganelli, S ;
Fernandez, M ;
Rambert, FA ;
Antonelli, T .
NEUROPHARMACOLOGY, 2000, 39 (11) :1974-1983
[8]   Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers [J].
Ferraro, L ;
Antonelli, T ;
O'Connor, WT ;
Tanganelli, S ;
Rambert, FA ;
Fuxe, K .
BIOLOGICAL PSYCHIATRY, 1997, 42 (12) :1181-1183
[9]  
GARATTINI S, 1987, BODY WEIGHT CONTROL, P261
[10]  
GOBBI M, 1992, N-S ARCH PHARMACOL, V345, P1